Hizentra
STN: BL 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: Hizentra
Manufacturer: CSL Behring AG, License #1766
Indication:
- Indicated for (1) Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older; (2) Maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).